Hypertension Impacts Peripheral Blood Leukocyte Composition

HomeHypertensionVol. 80, No. 1Hypertension Impacts Peripheral Blood Leukocyte Composition Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBHypertension Impacts Peripheral Blood Leukocyte Composition Lucas A. Salas and Karl T. Kelsey Lucas A. SalasLucas A. Salas Correspondence to: Lucas A. Salas, Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth Cancer Center, Lebanon, NH, Email E-mail Address: [email protected] https://orcid.org/0000-0002-2279-4097 Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth Cancer Center, Lebanon, NH (L.A.S.). Search for more papers by this author and Karl T. KelseyKarl T. Kelsey Correspondence to: Karl T. Kelsey, Department of Epidemiology and Pathology and Laboratory Medicine, Brown University, Email E-mail Address: [email protected] https://orcid.org/0000-0002-2302-1600 Department of Epidemiology and Pathology and Laboratory Medicine, Brown University, Providence, RI (K.T.K.). Search for more papers by this author Originally published7 Dec 2022https://doi.org/10.1161/HYPERTENSIONAHA.122.20422Hypertension. 2023;80:54–56This article is a commentary on the followingPeripheral Immune Cell Composition is Altered in Women Before and After a Hypertension DiagnosisIn this issue of Hypertension, Kresovich et al1 investigated how the immune system is affected by the presence and occurrence of high blood pressure, comparing women enrolled in the Sister Study with and without a diagnosis of hypertension and those with a de novo diagnosis in a 15-year follow-up. This prospective cohort collected information from 4124 women and prospectively identified incident cases of hypertension. A blood sample was collected at baseline, but no flow cytometry information was collected. Specifically, this article adds epidemiological evidence to a potential association between an increase in B cell proportions and a reduction in CD4(+) T naive cells and incident high blood pressure risk. In addition, they observed a higher proportion of neutrophils and lower proportions of CD4(+) T-cells, natural killers, and B cells in patients with hypertension compared with those without hypertension. The authors systematically evaluated the relationships between cell composition and systolic and diastolic blood pressure levels, the presence or absence of high blood pressure, and several groupings of the cells. The associations between increased B cell proportions and incidence of hypertension persisted in all the sensitivity analyses, similar to the association with systolic and diastolic blood pressure at baseline. Higher neutrophil-to-lymphocyte and lower lymphocyte-to-monocyte and CD4T/CD8T cell ratios were observed in prevalent hypertension.See related article, pp 43–53In the absence of flow cytometry information, to conduct this investigation, the researchers used high throughput DNA methylation information (Illumina HumanMethylation microarrays) and resolved the cell composition using cell deconvolution. This technique utilizes unique epigenetic fingerprints related to cell-type identity as a reference and retrieves the relative cell proportions in the peripheral blood using a statistical method called constrained projection/quadratic programming.2 In this article, the authors used, for the first time, an enhanced reference capable of resolving 12 different cell types.3 Using a DNA substrate allowed the interrogation of the cell composition in stored samples that could not be obtained using flow cytometry techniques. DNA, unlike RNA or cell surface markers, is stable and less prone to critical biases due to cell degradation. Roughly, DNA methylation (a covalent methylation bond to specific cytosines in the DNA strand) demarcates active versus inactive transcriptional areas, some unique to specific cell types. Cell deconvolution techniques offer new avenues for DNA methylation cytometry interrogation for researchers in different medical fields.4Interactions between leukocytes and blood pressure are a critical component of immune regulation that develops in response to acute and chronic stress. High blood pressure arises from a complex dysregulation of blood volume (sodium-water retention/excretion balance), cardiac output, and vascular rarefaction. Traditionally, this is related to an overactivated sympathetic nervous system, releasing catecholamines, increasing the cardiac output, generating vasoconstriction, and secondary activation of the renin-angiotensin-aldosterone system, further increasing vasoconstriction and promoting re-uptake of sodium/water in the kidney, expanding the blood volume. However, as with many complex diseases, other systems in the body are affected simultaneously, and more multifaceted endothelial-immune dysfunctions can play a role in the origin and evolution of high blood pressure.The link between inflammation and endothelial dysfunction has been teased in human autopsies5 showing autoantibodies in major arteries from hypertensive subjects and from small observational studies monitoring immunoglobulins levels in subjects with hypertension.6 Similarly, mouse models have shown an inconsistent role for B cells immunoglobulin production in these hypertension models.7,8 Several murine models have shown how T cell/mononuclear cell activation led to experimental hypertension, while experimental immunosuppression/increase in regulatory cells prevented high blood pressure in such models.9 For the T-cell component, immunosuppressed mice have shown a role of CD4(+) and CD8(+) T cells,10,11 and a potential link with CD4(+) T cells expressing interleukin-17A with an accumulation of interferon-gamma producing T cells.10 In particular, the role of CD8(+) T cells seems critical for the development of experimental hypertension in experimental models and should be further explored.11 Mechanistically, interleukin-17A is attractive as several tissues could be targeted simultaneously, including endothelium, vascular smooth muscle, fibroblasts, and kidney-specialized epithelium.12 Also experimentally, 3 mechanisms have been proposed to explain this: impaired vasodilation due to endothelial dysfunction, depletion of blood vessels due to inflammation, and vascular stiffening due to immune infiltration in the vessel wall.13 Interestingly, in humans, the information is still scarce, with few examples of epidemiological studies associating immune subpopulation changes in normotensive and hypertensive subjects not taking any antihypertensive medications,14,15 and hypertensive patients receiving immunosuppressants related to autoimmune disorders.16 These small studies looked at changes in the immune subpopulation averages that were different in patients with hypertension vs. those normotensive (even if they were not statistically significant) and how patients receiving immunosuppression showed some improvement in their blood pressure.Kresovich et al1 associations are consistent with findings in the animal models,9 as well as more complex Mendelian Randomization studies.17 A significant limitation with human studies is the limited access to samples of target organs (kidney, brain, large blood vessels), where some of the alterations related to the immune cell responses may be regulated.5,11,15 From the epidemiological perspective, Kresovich et al1 has some limitations in understanding differences in associations between different genetic ancestries (partially explored here using self-reported race as a proxy). This lack of population representation is an important issue that must be discussed in planned cohort studies; clarity on ancestry can help uncover potential associations that are differentially driven by any genetic component. Including more diverse populations also brings health disparities issues to the forefront for future work.18 The inverse relation between natural killers and cytotoxic T-cells by reported race is a gap that must be addressed in future studies. Unfortunately, the method used to interrogate the cell proportions cannot establish finer cell activation layers relevant for hypertension, such as the presence of TH17 T cells. On the other hand, the fact that this study used a women’s cohort brings other exciting questions, given that some of them must have experienced pregnancy and that preeclampsia is also associated with autoantibodies and potentially higher risk of high blood pressure later in life.19 Other inflammatory associations, such as the abnormal neutrophil activation in preeclampsia, are additional avenues of research that may benefit from these methodological approaches.20 At the same time, the results observed in this study may not be directly extrapolated to male populations, given sex-specific immune responses that have not been fully clarified in the literature due to a historically reduced representation of females in both experimental and clinical/epidemiological studies.21In the future, additional applications of DNA methylation cytometry using cell count information will help uncover other important relations, particularly differences related to genetic ancestry and sex differences. This large observational study suggests that humans’ immune subpopulations are linked to hypertension. Hopefully, this or similar methods will be incorporated as part of clinical practice to complement the complete cell blood count. Understanding the more subtle layers that characterize inflammation in chronic diseases such as hypertension may offer new avenues for additional personalized therapies complementing our current approaches.Article InformationSources of FundingL.A. Salas is supported by Congressionally Directed Medical Research Program/Department of Defense (W81XWH-20-1-0778) and National Institute for General Medical Sciences (P20 GM104416-09/8299). K.T. Kelsey was supported by a 2018 American Association for Cancer Research‐Johnson & Johnson Lung Cancer Innovation Science (18‐90‐52‐MICH) and NIH grant R01CA253976.Disclosures K.T. Kelsey is a founder and scientific advisor to Cellintec.FootnotesThe opinions expressed in this article are not necessarily those of the editors nor the American Heart Association.For Sources of Funding and Disclosures, see page 55.Correspondence to: Lucas A. Salas, Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth Cancer Center, Lebanon, NH, Email lucas.a.[email protected]eduCorrespondence to: Karl T. Kelsey, Department of Epidemiology and Pathology and Laboratory Medicine, Brown University, Email [email protected]eduReferences1. Kresovich J, Xu Z, Parks C, Sandler D, Taylor J. Peripheral immune cell composition is altered before and after a hypertension diagnosis.Hypertension. 2023; 80:43–53. doi: 10.1161/HYPERTENSIONAHA.122.20001LinkGoogle Scholar2. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. DNA methylation arrays as surrogate measures of cell mixture distribution.BMC Bioinf. 2012; 13:86. doi: 10.1186/1471-2105-13-86CrossrefMedlineGoogle Scholar3. Salas LA, Zhang Z, Koestler DC, Butler RA, Hansen HM, Molinaro AM, Wiencke JK, Kelsey KT, Christensen BC. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling.Nat Commun. 2022; 13:761. doi: 10.1038/s41467-021-27864-7CrossrefMedlineGoogle Scholar4. Kelsey KT, Wiencke JK. Immunomethylomics: a novel cancer risk prediction tool.Ann Am Thorac Soc. 2018; 15(Supplement_2):S76–S80. doi: 10.1513/AnnalsATS.201706-477MGCrossrefMedlineGoogle Scholar5. Köröskényi K, Juba F, Vajda G. Human vascular antigen complement consumption test of hypertensive patients (preliminary report).Experientia. 1961; 17:291–292. doi: 10.1007/BF02171445CrossrefGoogle Scholar6. Suryaprabha P, Padma T, Brahmaji Rao U. Increased serum IgG levels in essential hypertension.Immunol Lett. 1984; 8:143–145. doi: 10.1016/0165-2478(84)90067-1CrossrefMedlineGoogle Scholar7. Chen Y, Dale BL, Alexander MR, Xiao L, Ao M, Pandey AK, Smart CD, Davis GK, Madhur MS. Class switching and high-affinity immunoglobulin G production by B cells is dispensable for the development of hypertension in mice.Cardiovasc Res. 2021; 117:1217–1228. doi: 10.1093/cvr/cvaa187CrossrefMedlineGoogle Scholar8. Chan CT, Sobey CG, Lieu M, Ferens D, Kett MM, Diep H, Kim HA, Krishnan SM, Lewis CV, Salimova E, et al. Obligatory role for B cells in the development of angiotensin II-dependent hypertension.Hypertension. 2015; 66:1023–1033. doi: 10.1161/HYPERTENSIONAHA.115.05779LinkGoogle Scholar9. Drummond GR, Vinh A, Guzik TJ, Sobey CG. Immune mechanisms of hypertension.Nat Rev Immunol. 2019; 19:517–532. doi:10.1038/s41577-019-0160-5CrossrefMedlineGoogle Scholar10. Itani HA, McMaster WG, Saleh MA, Nazarewicz RR, Mikolajczyk TP, Kaszuba AM, Konior A, Prejbisz A, Januszewicz A, Norlander AE, et al. Activation of human t cells in hypertension: studies of humanized mice and hypertensive humans.Hypertension. 2016; 68:123–132. doi: 10.1161/HYPERTENSIONAHA.116.07237LinkGoogle Scholar11. Trott DW, Thabet SR, Kirabo A, Saleh MA, Itani H, Norlander AE, Wu J, Goldstein A, Arendshorst WJ, Madhur MS, et al. Oligoclonal CD8+ T cells play a critical role in the development of hypertension.Hypertension. 2014; 64:1108–1115. doi: 10.1161/HYPERTENSIONAHA.114.04147LinkGoogle Scholar12. Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, van Beusecum JP, Patrick DM, Smart CD, Kleyman TR, Kingery J, et al. Do inflammation and immunity hold the key to solving this epidemic?.Circ Res. 2021; 128:908. doi: 10.1161/CIRCRESAHA.121.318052LinkGoogle Scholar13. Zanoli L, Briet M, Empana JP, Cunha PG, Maki-Petaja KM, Protogerou AD, Tedgui A, Touyz RM, Schiffrin EL, Spronck B, et al; Association for Research into Arterial Structure, Physiology (ARTERY) Society, the European Society of Hypertension (ESH) Working Group on Vascular Structure and Function, and the European Network for Noninvasive Investigation of Large Arteries.Vascular consequences of inflammation: a position statement from the ESH working group on vascular structure and function and the ARTERY society.J Hypertens. 2020; 38:1682–1698. doi: 10.1097/HJH.0000000000002508CrossrefMedlineGoogle Scholar14. Mills PJ, Berry CC, Dimsdale JE, Ziegler MG, Nelesen RA, Kennedy BP. Lymphocyte subset redistribution in response to acute experimental stress: Effects of gender, ethnicity, hypertension, and the sympathetic nervous system.Brain Behav Immun. 1995; 9:61–69. doi: 10.1006/brbi.1995.1006CrossrefMedlineGoogle Scholar15. Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, Choi YS, Lee SH, Kang SM, Jang Y, et al. Immunosenescent CD8+ T Cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension.Hypertension. 2013; 62:126–133. doi: 10.1161/HYPERTENSIONAHA.113.00689LinkGoogle Scholar16. Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis.J Am Soc Nephrol. 2006; 17(12 suppl 3):S218–S225. doi: 10.1681/ASN.2006080918CrossrefMedlineGoogle Scholar17. Siedlinski M, Jozefczuk E, Xu X, Teumer A, Evangelou E, Schnabel RB, Welsh P, Maffia P, Erdmann J, Tomaszewski M, et al. White blood cells and blood pressure.Circulation. 2020; 141:1307–1317. doi: 10.1161/CIRCULATIONAHA.119.045102LinkGoogle Scholar18. Salas LA, Peres LC, Thayer ZM, Smith RW, Guo Y, Chung W, Si J, Liang L. A transdisciplinary approach to understand the epigenetic basis of race/ethnicity health disparities.Epigenomics. 2021; 13:1761–1770. doi: 10.2217/epi-2020-0080CrossrefMedlineGoogle Scholar19. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia.Hypertension. 2007; 50:269–275. doi: 10.1161/HYPERTENSIONAHA.107.091322LinkGoogle Scholar20. Hu Y, Li H, Yan R, Wang C, Wang Y, Zhang C, Liu M, Zhou T, Zhu W, Zhang H, et al. Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia.Thromb Haemost. 2018; 118:2064–2073. doi: 10.1055/s-0038-1675788CrossrefMedlineGoogle Scholar21. Tipton AJ, Sullivan JC. Sex and gender differences in T cells in hypertension.Clin Ther. 2014; 36:1882–1900. doi: 10.1016/j.clinthera.2014.07.011CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesPeripheral Immune Cell Composition is Altered in Women Before and After a Hypertension DiagnosisJacob K. Kresovich, et al. Hypertension. 2023;80:43-53 January 2023Vol 80, Issue 1 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/HYPERTENSIONAHA.122.20422PMID: 36475861 Originally publishedDecember 7, 2022 KeywordsmethylationEditorialsimmunityleukocyteshypertensionPDF download Advertisement SubjectsHigh Blood PressureInflammation